Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
AstraZeneca
Johnson and Johnson
Merck
Medtronic

Last Updated: May 24, 2022

Abraxis Pharm Company Profile


✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ABRAXIS PHARM, and what generic and branded alternatives to ABRAXIS PHARM drugs are available?

ABRAXIS PHARM has one hundred and thirteen approved drugs.



Summary for Abraxis Pharm
US Patents:0
Tradenames:63
Ingredients:60
NDAs:113

Drugs and US Patents for Abraxis Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 089187-001 Mar 28, 1986 DISCN No No See Plans and Pricing See Plans and Pricing
Abraxis Pharm NALBUPHINE nalbuphine hydrochloride INJECTABLE;INJECTION 070752-001 Sep 24, 1986 DISCN No No See Plans and Pricing See Plans and Pricing
Abraxis Pharm FLUOROURACIL fluorouracil INJECTABLE;INJECTION 089152-001 Mar 21, 1986 DISCN No No See Plans and Pricing See Plans and Pricing
Abraxis Pharm CEPHAPIRIN SODIUM cephapirin sodium INJECTABLE;INJECTION 062723-005 Nov 17, 1986 DISCN No No See Plans and Pricing See Plans and Pricing
Abraxis Pharm CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride INJECTABLE;INJECTION 084911-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing
Abraxis Pharm NALOXONE HYDROCHLORIDE naloxone hydrochloride INJECTABLE;INJECTION 070648-001 Nov 17, 1986 DISCN No No See Plans and Pricing See Plans and Pricing
Abraxis Pharm PROCAINE HYDROCHLORIDE procaine hydrochloride INJECTABLE;INJECTION 080421-002 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
McKinsey
McKesson
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.